Wikipedia talk:WikiProject Pharmacology/Guideline
| This is the talk page for discussing improvements to the WikiProject Pharmacology/Guideline redirect. |
|
Specific drug vs drug class details edit
Drug articles suffer perhaps more than many topics from information duplication - i.e. each member of a drug group being loaded with information on mechanism/indication/adverse effects that are common to the drug group as a whole and better left in the main article. Merely copying long lists of side-effects is unhelpful, and the patchy depth of adding details to one drug compared to another then becomes confusing (is drug A really associated with less side effects than B, or does the article on B just not have the details entered to the same degree of coverage, or are the details in article A to an excessive level that needs pruning back?).
I think some mention needs to be made that for these sections, discusion should not excessively duplicate the more thorough coverage in the article on the drug-group, and particularly in discussing effects & side-effects it is then the distinguishing features (greater receptor selectivity, or difference in adverse effect profile) that needs be mentioned. David Ruben Talk 02:07, 17 February 2010 (UTC)
Merge? edit
Should this be merged with Wikipedia:WikiProject Pharmacology/Style guide? --ἀνυπόδητος (talk) 19:36, 12 July 2010 (UTC)
- I think it might be better to merge it with WP:MEDMOS, which already covers some of this information. WhatamIdoing (talk) 16:19, 16 July 2010 (UTC)
- I think WP:PHARM deserves its own style guide. It would clutter up WP:MOSMED if we put all this material there. --ἀνυπόδητος (talk) 20:05, 16 July 2010 (UTC)